About
Veteran of the pharmaceutical industry with over 20 years at Eli Lilly, including service as Chief Medical Officer from 2008 to 2021. He led development of therapeutics in women's health, endocrinology, and neuroscience through regulatory approval and global launch. Holds medical qualifications and fellowships in pharmaceutical medicine and obstetrics/gynaecology.
Experience
- Ophirex, Inc.Chairman of the Boardcurrent2021 — present
- MapLight Therapeutics, Inc.Board Membercurrent2023 — present
- Cardiol Therapeutics Inc.Board Membercurrent2025 — present
- DAP HealthBoard Membercurrent2025 — presentPalm Springs, California, United States
- Recode VenturesEquity Partnercurrent2024 — presentSan Francisco Bay Area
- UkkoAdvisorcurrent2021 — present
- Biolojic Design, Ltd.Advisorcurrent2021 — present
- Lindus HealthAdvisorcurrent2024 — present
- Xentria, Inc.Advisorcurrent2024 — present
- Chemify LimitedAdvisorcurrent2025 — present
- Aion MedicinesAdvisorcurrent2025 — present
- Cambridge Innovation CapitalAdvisory Panelcurrent2021 — present
- Carmot Therapeutics, Inc.Board Member2022 — 2024
- Eli Lilly and CompanyChief Medical Officer, Senior VIce President2008 — 2021
- Eli Lilly and CompanyVice President, Global Patient Safety2006 — 2008
- Eli Lilly and CompanyProduct Team Leader2005 — 2006
- Eli Lilly and CompanyGroup Medical Director2004 — 2005
- Eli Lilly and CompanyMedical Director2000 — 2004
- Eli Lilly and CompanyEuropean Development Physician1998 — 2000
- OrganonMedical Director1991 — 1998
- King's College Hospital NHS Foundation TrustRsearch Fellow1988 — 1991
- King's College Hospital NHS Foundation TrustSenior House Officer1986 — 1988
- The Royal Marsden NHS Foundation TrustSenior House Officer1985 — 1986
- Chelsea and Westminster Hospital NHS Foundation TrustSenior House Officer1984 — 1985
Skills & more
Leadership11Drug Development51Regulatory Affairs47Medical Affairs45Pharmaceutical Industry24Clinical Trials15Clinical Development14Patient Safety12Biotechnology4GCP5Pharmacovigilance4Clinical Research3
+4 more
Regulatory SubmissionsGlobal Drug DevelopmentDrug SafetyPolicy- MFFP — Faculty of Pharmaceutical Medicine
- FFFP — Faculty of Pharmaceutical Medicine
- MRCOG — Royal College of Obstetricians and Gynaecologists | RCOG
- FRCOG — Royal College of Obstetricians and Gynaecologists | RCOG
- MBBS — University of London
From Tim's professional profile.
Colleagues at Recode Ventures
Armen A. Vidian
Managing Partner at Recode Ventures
Baroness Nicola Blackwood
Equity Partner at Recode Ventures
Jeff Berkowitz
Equity Partner at Recode Ventures
Julie Norledge
Executive Assistant at Recode Ventures
Lloyd Appel
Chief Financial Officer at Differential Ventures
Oscar Marshall
Venture Fellow at Recode Ventures
Sir Bruce Keogh
Equity Partner at Recode Ventures
Vishal Gulati
Founder & Managing Partner at Recode Ventures
Frequently asked questions
- Who is Tim Garnett?
- Veteran of the pharmaceutical industry with over 20 years at Eli Lilly, including service as Chief Medical Officer from 2008 to 2021. He led development of therapeutics in women's health, endocrinology, and neuroscience through regulatory approval and global launch. Holds medical qualifications and fellowships in pharmaceutical medicine and obstetrics/gynaecology.
- Where does Tim Garnett work?
- Tim Garnett is Equity Partner at Recode Ventures.
- Where did Tim Garnett go to school?
- Tim Garnett studied at St George's, University of London (for students and alumni) (Bachelor of Medicine, Bachelor of Surgery - MBBS, Medicine).
Same school
Also attended St George's, University of London (for students and alumni)1
Shared employers
Also worked at Ukko4
Also worked at Biolojic Design, Ltd.3
Also worked at Eli Lilly and Company83
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi Invest
+ 77 more
